Modulation by testosterone of an endogenous hERG potassium channel current

Journal of Physiology and Pharmacology

Volumn 59, Issue 3, 2008, Pages 395-407

  Ridley, J M ^a,c   Shuba, Y M ^b   James, A F ^a   Hancox, J C ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b INSTITUTE OF HYDROBIOLOGY   (Ukraine)

^c Xention Limited   (United Kingdom)

Author keywords

Flutamide; Gender; hERG; Human ether a go go related gene; IKr; Rapid delayed rectifier; Testosterone

Indexed keywords

FLUTAMIDE; POTASSIUM CHANNEL HERG; TESTOSTERONE; WORTMANNIN;

ACTION POTENTIAL; AMPLITUDE MODULATION; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; ELECTROPHYSIOLOGY; HEART REPOLARIZATION; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PATCH CLAMP; RECEPTOR AFFINITY; SEX DIFFERENCE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANDROGEN ANTAGONISTS; ANDROSTADIENES; AXONAL TRANSPORT; CELL LINE; ELECTRIC STIMULATION; ELECTROPHYSIOLOGY; ENZYME INHIBITORS; ETHER-A-GO-GO POTASSIUM CHANNELS; FLUTAMIDE; HUMANS; PATCH-CLAMP TECHNIQUES; RECEPTORS, ANDROGEN; TEMPERATURE; TESTOSTERONE;

EID: 53649086649     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Sanguinetti MC, Tristani-Firouzi M. hERG potassium channels and cardiac arrhythmia. Nature 2006; 440: 463-469.
2. Tamargo J, Caballero R, Gómez R, Valenzuela C, Delpón E. Pharmacology of cardiac potassium channels. Cardiovasc Res 2004; 62: 9-33.
3. Witchel HJ, Hancox JC, Familial and acquired long QT syndrome and the cardiac rapid delayed rectifier potassium current. Clin Exp Pharmacol Physiol 2000; 27: 753-766.
4. Surawicz B. Puzzling gender repolarization gap. J Cardiovas Electrophysiol 2001; 12: 613-615.
5. Pham TV, Rosen M. Sex, hormones, and repolarization. Cardiovas Res 2002; 253: 740-751.
6. James AF, Choisy SC, Hancox JC. Recent advances in understanding sex differences in cardiac repolarization. Prog Biophys Mol Biol 2007; 94: 265-319.
7. Liu X-K, Katchman A, Drici M-D, et al. Gender difference in the cycle length-dependent QT and potassium currents in rabbits. J Pharm Exp Ther 1998; 285: 672-679.
8. James AF, Arberry LA, Hancox JC. Gender differences in ventricular myocyte repolarization in the guinea-pig. Bas Res Cardiol 2004: 99; 183-192.
9. Liu X-K, Katchman A, Whitfield BH, et al. In vivo androgen treatment shortens the QT-interval and increases the densities of inward and delayed rectifier potassium currents in orchiectomized male rabbits. Cardiovasc Res 2003; 57: 28-36.
10. Shuba YM, Degtiar VE, Osipenko VN, Naidenov VG, Woosley RL. Testosterone-mediated modulation of HERG blockade by proarrhythmic agents. Biochem Pharmacol 2001; 62: 41-49.
11. Bai C-X, Kurokawa J, Tamagawa M, Nakaya H, Furukawa T. Nontranscriptional regulation of cardiac repolarization currents by testosterone. Circulation 2005; 112: 1701-1710.
12. + current highly conserved in tumors of different histogenesis: a selective advantage for cancer cells. Cancer Res 1998; 58: 815-822.
13. + channel expression in SH-SY5Y cells. Eur J Pharmacol 2003; 459: 121-129
14. Su Z, Limberis J, Martin RL, et al. Functional consequences of methionine oxidation of hERG potassium channels. Biochem Pharmacol 2007; 74: 702-711.
15. Yerramillo-Rao P, Garafolo O, Whatley S., Leigh PN, Gallo JM. Androgen-controlled specific gene expression in neuroblastoma cells. J Neurol Sci 1995; 129: S131-S135.
16. Butler R, Leigh PN. Androgen-induced up-regulation of tubulin isoforms in neuroblastoma cells. J Neurochem 2001; 78: 854-861.
17. Milnes JT, Crociani O, Arcangeli A, Hancox JC, Witchel HJ. Blockade of HERG potassium currents by fluvoxamine: incomplete attenuation by S6 mutations at F656 or Y652. Br J Pharmacol 2003; 139: 887-898.
18. + current and prolongation of the guinea-pig ventricular action potential by 4-aminopyridine. J Physiol 2003; 549: 667-672.
19. Dorgan JF, Fears TR, McMahon RP, Aronson Friedman L, Patterson BH, Greenhut SF. Measurement of steroid sex hormones in serum: a comparison of radioimmunoassay and mass spectrometry. Steroids 2002; 67: 151-158.
20. + channels expressed in HEK293 cells requires basal protein kinase B activity. FEBS Lett 2003; 534: 125-132.
21. Gao W, Kim J, Dalton JT. Pharmacokinetics and pharmacodynamics of nonsteroidal androgen receptor ligands. Pharmaceutical Research 2006; 23: 1641-1658.
22. Oudit GY, Sun H, Kerfant BG, Crackower MA, Penninger JM, Backx PH. The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease. J Mol Cell Cardiol 2004; 37: 449-471.
23. Losel RM, Falkenstein E, Feuring M, et al. Nongenomic steroid actions: controversies, questions and answers. Physiol Rev 2003; 83: 965-1016.
24. Storey NM, Gentile S, Ullah H, et al. Rapid signaling at the plasma membrane by a nuclear receptor for thyroid hormone. Proc Natl Acad Sci USA 2006; 103; 5197-5201.
25. Arcangeli A, Rosati B, Crociani O, et al. Modulation of HERG current and herg gene expression during retinoic acid treatment of human neuroblastoma cells: potentiating effects of BDNF. J Neurobiol 40: 214-225.
26. Cherubini A, Hofmann G, Pillozzi S, et al. Human ether-a-go-go-related gene 1 channels are physically linked to beta1 integrins and modulate adhesion-dependent signaling. Mol Cell Biol 2005; 16: 2972-2983.
27. Arcangeli A. Expression and role of hERG channels in cancer cells. Novartis Found Symp. 205; 266: 225-232.
28. Zhao J, Wei XL, Jia YS, Zheng JQ. Silencing of herg gene by shRNA inhibits SH-SY5Y cell growth in vitro and in vivo. Eur J Pharmacol, 2008; 579: 50-57.
29. + channel block-related cardiotoxicity by the H1 receptor blocker cetirizine compared with other second generation antihistamines. Mol Pharmacol 1998; 54: 113-121.